第二阶段a,在高风险恶化的COPD患者中对Mitiperstat与安慰剂进行随机试验 (CRESCENDO)
Rod Hughes1, Wayne Brailsford2, João Ferreira1
1Respiratory and Immunology Biometrics and Statistical Innovation, AstraZeneca, Cambridge, UK.
International journal of chronic obstructive pulmonary disease
|October 1, 2025
概括
作为MPO抑制剂的mitiperstat可以减少COPD患者的氧化应激和炎症. 这项研究调查了其在高风险慢性阻塞性肺病患者中减少恶化和改善肺功能方面的潜力.
科学领域:
- 肺部医学 肺部医学
- 药理学 药理学是指药理学的学科.
- 炎症研究 炎症研究
背景情况:
- 中性质炎症是COPD的标志,与疾病进展和不良结果有关.
- 中性粒细胞释放的髓氧化酶 (MPO) 有助于COPD的组织损伤和恶化.
- 目前的治疗方法不能完全解决COPD中MPO介导的损伤.
研究的目的:
- 评估一种新的口服MPO抑制剂mitiperstat的有效性和安全性,用于COPD患者.
- 为了确定mitiperstat是否可以减少肺氧化应激,炎症和恶化.
- 评估米蒂珀斯塔特对COPD患者的症状,肺功能和并发症的影响.
主要方法:
- 克雷斯多研究是一项2a期,随机,双盲,安慰剂对照试验.
- 这项为期24周的研究涉及40至80岁的患有高风险慢性肺炎的患者,随机分配给米蒂珀斯塔5毫克或安慰剂.
- 主要终点:到第一个CompEx事件的时间 (疾病恶化的复合体).
主要成果:
- 结果正在等待,因为研究仍在进行中.
- 每位患者将在18-30周内收集有效性和安全性数据.
- 这项研究旨在提供关于MPO抑制对COPD管理的见解.
结论:
- 米蒂珀斯塔特正在作为一种新的COPD治疗药物进行研究.
- 该研究采用以患者为中心的设计,以改善招聘和现实世界的相关性.
- 这些发现可能通过向MPO驱动的炎症来提供一种新的方法来管理COPD.
更多相关视频
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
734
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
734
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:22Chronic Obstructive Pulmonary Disease
2.3K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.3K